INSIGHTS ON CLINICAL TRIAL PARTNERING

• Unlocking Recruitment Potential In Trial-Naïve Sites

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• The Right CRO Is An Extension Of Your Brand: Here's Why It Matters

  For sponsors eyeing Australia, CROs with deep local expertise unlock the region’s advantages and, coupled with a global outlook, can ensure your trial aligns with international regulatory expectations.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Delivering Specialist Neurology Support

  Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

• Working With A Specialty Oncology CRO Versus A Large Generalist CRO

  10/2/2025

  Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.

• Are You Paying Participants Enough? Your Top Questions Answered

  6/24/2025

  Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.

• Accelerate Drug Development With Master Protocols

  5/15/2025

  Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

• Considerations For Drug-Device Combination Products In Rare Diseases

  8/7/2025

  The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.

• Navigating Biases In Clinical Trial Vendor Selection

  10/21/2025

  Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.